|
|
|
| Webinar: Advancing Therapeutic Discovery With Reproducible High Throughput Electroporation | Unlock faster breakthroughs in cell therapy and drug discovery with MaxCyte’s high-throughput electroporation platform. This must-attend webinar showcases how to conquer cost, timeline, and scalability hurdles with rapid 96-sample processing in minutes. Discover precision energy control, powerful CRISPR CAR-T applications, and seamless scalability from research to GMP manufacturing, plus expert insights and real-world strategies driving high-impact results. Click here to learn more. |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Erin Harris, chief editor, Cell & Gene | Trafficking and entry remain some of the most fundamental and unresolved barriers in solid tumor cell therapy. Building off of a panel from PMWC 2026, uncover the next steps in how to improve trafficking and entry to enable CAR T-cells to reach and function within solid tumors. | |
|
|
| The Art Of Phosphitylation | Application Note | Entegris, Inc. | Phosphorylation is key for bioactives; master selecting the right protecting groups. Explore how new technologies and high-selectivity phosphoramidites refine and scale your chemical processes. |
|
|
|
|
| Innovating The mAb Characterization Process | Case Study | Danaher Life Sciences | Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process. |
|
|
| New Solutions For Your Engineered Immune Cell Analytics | Webinar | Miltenyi Biotec | Discover solutions for optimizing immune cell engineering workflows, from target identification to product monitoring and beyond, along with tools to enhance efficiency and accuracy at every stage. |
|
|
|
|
| The 5th In Vivo Cell Engineering & Gene Editing Summit | The 5th In Vivo Cell Engineering & Gene Editing Summit brings together leading scientists, biopharma innovators, and industry strategists to advance the next generation of in vivo delivery and editing technologies. With growing momentum behind extrahepatic targeting, early clinical readouts, and scalable manufacturing, this meeting offers critical insights to accelerate IND‑enabling work and shape the future of accessible, durable in vivo therapies. Find out more. |
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
